Suppr超能文献

一种用于高产重组志贺毒素B链蛋白的简单补料分批培养工艺的开发。

Development of a simple fed-batch process for the high-yield production of recombinant shiga toxin B-chain protein.

作者信息

Sharma Kulbhushan, Gupta Pallavi, Kumar Singh Anil, Gopalan N, Kumar Dhaked Ram, Lakshmana Rao P V

机构信息

Bioprocess Scale-Up Facility, Defence Research and Development Establishment, Jhansi Road, Gwalior 474002, India.

出版信息

Protein Pept Lett. 2012 Feb;19(2):228-37. doi: 10.2174/092986612799080374.

Abstract

Shiga toxins are one of the very potent agents for causing dysentery, diarrhoea and haemolytic uremic syndrome with very low LD50. For better understanding of their biology, detection and neutralization, the components of toxins are needed to be expressed and purified in bulk amounts. However, following traditional expression procedures, this task is very tedious as the yield of the toxin is very low. In this manuscript, we have described the optimization of media for enhanced production of recombinant Shiga toxin B (rStx-B) chain protein in Escherichia coli. This protein is known to have neutralization ability against shiga toxins. Furthermore, fed-batch cultivation process in E. coli was also developed in the optimized medium. Expression was induced with 1 mM isopropyl-beta-thiogalactoside (IPTG). The purification of protein involved Ni-NTA affinity chromatography under native conditions followed by gel filtration chromatography. After fed-batch cultivation, the recombinant E. coli resulted in cell weight and purified protein of about 19.41 g/l (dry cell weight, 11.38 g/l) and 30 mg/l of culture, respectively. The purity of the recombinant StxB protein was checked by sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis. Reactivity of this protein was determined by Western blotting as well as indirect ELISA using specific antibodies. These results establish the application of this protein for diagnosis of shiga toxin infection or for neutralizing the toxicity.

摘要

志贺毒素是导致痢疾、腹泻和溶血尿毒综合征的极为强效的病原体之一,其半数致死剂量(LD50)极低。为了更好地了解其生物学特性、检测方法及中和作用,需要大量表达和纯化毒素的各个组分。然而,按照传统的表达程序,这项任务非常繁琐,因为毒素的产量很低。在本论文中,我们描述了用于提高重组志贺毒素B(rStx - B)链蛋白在大肠杆菌中产量的培养基优化方法。已知该蛋白具有中和志贺毒素的能力。此外,还在优化后的培养基中开发了大肠杆菌的补料分批培养工艺。用1 mM异丙基 - β - 硫代半乳糖苷(IPTG)诱导表达。蛋白纯化过程包括在天然条件下进行镍 - 氮三乙酸(Ni - NTA)亲和层析,随后进行凝胶过滤层析。补料分批培养后,重组大肠杆菌的细胞重量和纯化蛋白产量分别约为19.41 g/l(干细胞重量为11.38 g/l)和30 mg/l培养物。通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳分析检测重组StxB蛋白的纯度。使用特异性抗体通过蛋白质印迹法以及间接酶联免疫吸附测定法(ELISA)确定该蛋白的反应活性。这些结果证实了该蛋白在志贺毒素感染诊断或毒性中和方面的应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验